For patients with BMI 35 kg/m (regardless of comorbidities) or BMI 30-34.9 kg/m with metabolic disease, bariatric surgery consultation may be appropriate, according to 2022 American Society for Metabolic and Bariatric Surgery guidelines
Scafidi S, Fiskum G, Lindauer SL, Bamford P, Shi D, Hopkins I, McKenna MC
Very concentrated
Featuring L-Carnitine Tartrate, Choline Bitartrate, HCA, and Russian Tarragon, Carne Diem is designed to support endurance, energy utilization, and training performance while remaining completely stimulant-free
Weight loss was associated with improvements in: Blood pressure Lipid profiles Sleep apnoea Joint pain Quality of life These findings led regulatory bodies to approve semaglutide (Wegovy) and tirzepatide (Zepbound) for obesity treatment, even in the absence of diabetes signalling a paradigm shift in how weight and metabolic risk are medically managed